Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 265, Issue 7, 2015, Pages 589-600

  Hasan, Alkomiet ^a   Wolff Menzler, Claus ^b   Pfeiffer, Sebastian ^c   Falkai, Peter ^a   Weidinger, Elif ^a   Jobst, Andrea ^a   Hoell, Imke ^b   Malchow, Berend ^a   Yeganeh Doost, Peyman ^b   Strube, Wolfgang ^a   Quast, Silke ^b   Müller, Norbert ^a   Wobrock, Thomas ^b,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Institut für Anwendungsorientierte Forschung und Klinische Studien GmbH   (Germany)

^d Darmstadt Dieburg Clinics   (Germany)

Author keywords

Noninvasive brain stimulation; Patient controlled neurostimulation; Schizophrenia; tVNS; Vagus nerve

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTRODE IMPLANT; EXTERNAL AUDITORY CANAL; FEASIBILITY STUDY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; IMPLANTED VAGUS NERVE STIMULATOR; INTERVENTION STUDY; MALE; MENTAL PATIENT; PATIENT COMPLIANCE; PATIENT SAFETY; PATIENT SATISFACTION; PILOT STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SHAM PROCEDURE; SKIN IRRITATION; SKIN PAIN; TRANSCUTANEOUS NERVE STIMULATION; TRANSCUTANEOUS VAGUS NERVE STIMULATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PSYCHOLOGY; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; YOUNG ADULT;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 84941942930     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-015-0618-9     Document Type: Article

References (53)

1. Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the calgary depression scale. Br J Psychiatry (Suppl 22):39–44
2. Andreasen NC (1983) Scale for the assessment of negative symptoms. University of Iowa Press, Iowa City
3. Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger wortflüssigkeits-test (rwt): Handanweisung. In: Hogrefe, Verlag für Psychologie., Göttingen
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
5. Berch DB, Krikorian R, Huha EM (1998) The corsi block-tapping task: methodological and theoretical considerations. Brain Cogn 38:317–338
6. Boon P, Moors I, De Herdt V, Vonck K (2006) Vagus nerve stimulation and cognition. Seizure 15:259–263
7. Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E (2012) Examining transcranial direct-current stimulation (tdcs) as a treatment for hallucinations in schizophrenia. Am J Psychiatry 169:719–724
8. Buchanan RW (2007) Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull 33:1013–1022
9. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W, Schizophrenia Patient Outcomes Research T (2010) The 2009 schizophrenia port psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36:71–93
10. de Haan L, Weisfelt M, Dingemans PM, Linszen DH, Wouters L (2002) Psychometric properties of the subjective well-being under neuroleptics scale and the subjective deficit syndrome scale. Psychopharmacology 162:24–28
11. Dietrich S, Smith J, Scherzinger C, Hofmann-Preiss K, Freitag T, Eisenkolb A, Ringler R (2008) A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional mri. Biomed Technik Biomed Eng 53:104–111
12. Dlabac-de Lange JJ, Knegtering R, Aleman A (2010) Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry 71:411–418
13. Englot DJ, Chang EF, Auguste KI (2011) Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 115:1248–1255
14. Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235–241
15. Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A, Leucht S (2015) Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry 72:14–21
16. Gerlach J, Korsgaard S, Clemmesen P, Lauersen AM, Magelund G, Noring U, Povlsen UJ, Bech P, Casey DE (1993) The st. Hans rating scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 87:244–252
17. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
18. Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ (2012) World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13:318–378
19. Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ, Schizophrenia WTFoTGf (2015) World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of schizophrenia part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry 16:142–170
20. Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ, World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for S (2012) World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13:318–378
21. He W, Jing X, Wang X, Rong P, Li L, Shi H, Shang H, Wang Y, Zhang J, Zhu B (2013) Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial. Epilepsy Behav E&B 28:343–346
22. Hein E, Nowak M, Kiess O, Biermann T, Bayerlein K, Kornhuber J, Kraus T (2013) Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study. J Neural Transm 120:821–827
23. Helmstaedter C, Lendt M, Lux S (2000) Testhandbuch verbaler lern- und merkfähigkeitstest. Hogrefe Verlag, Göttingen
24. Henry TR, Bakay RA, Pennell PB, Epstein CM, Votaw JR (2004) Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: ii. Prolonged effects at high and low levels of stimulation. Epilepsia 45:1064–1070
25. Homan P, Kindler J, Hauf M, Hubl D, Dierks T (2012) Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations. Transl Psychiatry 2:e189
26. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (panss) for schizophrenia. Schizophr Bull 13:261–276
27. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR (2006) The nimh-matrics consensus statement on negative symptoms. Schizophr Bull 32:214–219
28. Kraus T, Hosl K, Kiess O, Schanze A, Kornhuber J, Forster C (2007) Bold fmri deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 114:1485–1493
29. Kraus T, Kiess O, Hosl K, Terekhin P, Kornhuber J, Forster C (2013) Cns bold fmri effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal—a pilot study. Brain Stimul 6:798–804
30. Kreuzer PM, Landgrebe M, Husser O, Resch M, Schecklmann M, Geisreiter F, Poeppl TB, Prasser SJ, Hajak G, Langguth B (2012) Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. Front Psychiatry 3:70
31. Kreuzer PM, Landgrebe M, Resch M, Husser O, Schecklmann M, Geisreiter F, Poeppl TB, Prasser SJ, Hajak G, Rupprecht R, Langguth B (2014) Feasibility, safety and efficacy of transcutaneous vagus nerve stimulation in chronic tinnitus: an open pilot study. Brain Stimul 7:740–747
32. Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L (2014) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 125:2150–2206. doi:10.1016/j.clinph.2014.05.021
33. Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lassig B, Salanti G, Davis JM (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382:951–962
34. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The uku side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1–100
35. Martin JL, Martin-Sanchez E (2012) Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry 27:147–155
36. Mojtabai R, Lavelle J, Gibson PJ, Sohler NL, Craig TJ, Carlson GA, Bromet EJ (2002) Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatr Serv 53:337–339
37. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
38. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK (2006) Vns therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345–1355
39. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497
40. Perez SM, Carreno FR, Frazer A, Lodge DJ (2014) Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia. J Neurosci 34:9261–9267
41. Petrides G, Malur C, Braga RJ, Bailine SH, Schooler NR, Malhotra AK, Kane JM, Sanghani S, Goldberg TE, John M, Mendelowitz A (2015) Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry 172:52–58
42. Prikryl R, Kucerova HP (2013) Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia? J ECT 29:67–74
43. Rosenquist PB, Miller B, Pillai A (2014) The antipsychotic effects of ect: a review of possible mechanisms. J ECT 30:125–131
44. Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, Oliver N, Zboyan H (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol 14:53–62
45. Schaub D, Juckel G (2011) PSP scale: german version of the personal and social performance scale: valid instrument for the assessment of psychosocial functioning in the treatment of schizophrenia. Der Nervenarzt 82:1178–1184
46. Schmidt KH (1992) Der wortschatztest (wst). Beltz Test GmbH, Weinheim
47. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (m.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59(Suppl. 20):22–33 (quiz 34-57)
48. Shi C, Yu X, Cheung EF, Shum DH, Chan RC (2013) Revisiting the therapeutic effect of rtms on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res 215:505–513
49. Slotema CW, Blom JD, van Lutterveld R, Hoek HW, Sommer IE (2014) Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations. Biol Psychiatry 76:101–110
50. Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M, Kasper BS, Hammen T, Rzonsa M, Pauli E, Ellrich J, Graf W, Hopfengartner R (2012) Transcutaneous vagus nerve stimulation (t-vns) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 53:e115–e118
51. Tombaugh TN (2004) Trail making test a and b: normative data stratified by age and education. Arch Clin Neuropsychol 19:203–214
52. Wani A, Trevino K, Marnell P, Husain MM (2013) Advances in brain stimulation for depression. Ann Clin Psychiatry 25:217–224
53. Wobrock T, Guse B, Cordes J, Wolwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A (2015) Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry 77:979–988